Jona has expanded its Clinical Gut Microbiome Analysis platform by adding stool biomarkers such as calprotectin, secretory IgA, and short-chain fatty acids alongside deep shotgun metagenomic sequencing and its AI-powered interpretation engine.
The company says the enhanced test combines microbiome sequencing, stool chemistry, and an AI model trained on more than 220,000 scientific studies to provide clinicians with more actionable insights into gut health. Jona also uses a “Digital Twin” technology designed to simulate how diet, supplements, and lifestyle changes may influence an individual’s microbiome before interventions are implemented.
The launch reflects a broader trend in microbiome diagnostics: moving beyond simply measuring gut bacteria toward integrating biomarkers, AI-driven interpretation, and personalized recommendations aimed at making microbiome testing more clinically useful for practitioners.